Hypotension in Medical Technology
Navigation Links
Hypotension in Medical Technology
... in the prescribing information .
hypotension in Volume- or Salt-Depleted Patients
In ... with high doses of diuretics), symptomatic hypotension may occur after initiation of treatment with ... should start under close medical supervision. If hypotension does occur, the patient should be placed in the ...
... AEs included: dizziness (3.4 percent), hypotension (2.2 percent), and/or headache (1.1 percent). ... patients, 2.2%), headache (4 patients, 2.2%), and hypotension (4 patients, 2.2%). Among individual treatment ... Mortality in the prescribing information. hypotension in Volume- or Salt-Depleted Patients In ...
... Fetal/Neonatal Morbidity and Mortality. hypotension in Volume- or Salt-Depleted Patients In ... and/or salt-depleted patients, symptomatic hypotension due particularly to the olmesartan component may ... to amlodipine in AZOR is gradual in onset, acute hypotension has rarely been reported after oral ...
... include new or worsening peripheral neuropathy, hypotension throughout therapy, cardiac and pulmonary ... pain (each 15%), bone pain (14%), back pain and hypotension (each 13%), herpes zoster, nasopharyngitis, upper ... (13% vs 7%), abdominal pain upper (12% vs 9%), hypotension (12% vs 3%), dyspepsia (11% vs 7%), ...
... include new or worsening peripheral neuropathy, hypotension throughout therapy, cardiac and pulmonary ... pain (each 15%), bone pain (14%), back pain and hypotension (each 13%), herpes zoster, nasopharyngitis, upper ... (13% vs 7%), abdominal pain upper (12% vs 9%), hypotension (12% vs 3%), dyspepsia (11% vs 7%), ...
... include new or worsening peripheral neuropathy, hypotension throughout therapy, cardiac and pulmonary ... pain (each 15%), bone pain (14%), back pain and hypotension (each 13%), herpes zoster, nasopharyngitis, upper ... (13% vs 7%), abdominal pain upper (12% vs 9%), hypotension (12% vs 3%), dyspepsia (11% vs 7%), ...
... (13% vs 7%), abdominal pain upper (12% vs 9%), hypotension (12% vs 3%), dyspepsia (11% vs ... include new or worsening peripheral neuropathy, hypotension throughout therapy, cardiac and pulmonary ... pain (each 15%), bone pain (14%), back pain and hypotension (each 13%), herpes zoster, nasopharyngitis, upper ...
... as the incidence (%) in these 98 patients: hypotension (50%), back pain (30%), dyspnea (28%), ... type of treatment will depend on whether edema or hypotension is the primary clinical problem. Pre-existing low ... (61%), infection (48%), pain (48%), edema (47%), hypotension (36%), anorexia (36%), and rash (34%). ...
... resulted in accidents. Hallucinations and postural (orthostatic) hypotension may occur. In clinical trials for early PD using immediate release ... of pramipexole that were more frequent than with placebo are postural hypotension (53% vs. 48%), dyskinesia (47% vs. 31%), extrapyramidal syndrome (28% vs. ...
... Morbidity and Mortality in the prescribing information. hypotension in Volume- or Salt-Depleted Patients In patients with an activated ... (eg, those being treated with high doses of diuretics), symptomatic hypotension may occur after initiation of treatment with BENICAR. Treatment should ...
... Morbidity and Mortality in the prescribing information. hypotension in Volume- or Salt-Depleted Patients In patients with an activated ... (e.g., those being treated with high doses of diuretics), symptomatic hypotension may occur after initiation of treatment with BENICAR. Treatment should ...
... (29.9%), sneezing (16.3%), skin sensation (10.9%), nausea (9%), and hypotension (6.3%). These events were generally transient. Four serious AEs possibly or probably related to KYNAPID occurred in three patients and included hypotension (2 events), complete atrioventricular block and cardiogenic shock. About ...
... proprietary products for the therapeutic management of acute and chronic hypotension and hypotension-related disorders. The lead development compound is a ... for Migraine, and MTR105 (i.v. formulation) for the treatment of hypotension associated with cardiac (CABG) surgery. Meditor's patent portfolio ...
... of care includes diuretics and vasodilators. Available agents from both of these classes of agents have been associated with renal impairment, hypotension and adverse outcomes. About Relaxin Relaxin is a naturally occurring peptide hormone that acts as a systemic and renal vasodilator. ...
... higher levels of prolactin elevation than other antipsychotic agents. Orthostatic Hypotension: RISPERDAL(R) CONSTA(R) may induce orthostatic hypotension associated with dizziness, tachycardia, and in some patients, syncope, especially during the initial dose-titration period. Monitoring should be ...
... treatment effect, led to treatment discontinuation in only 2.8 percent of patients, and does not pose a safety concern. Incidences of orthostatic hypotension among RAPAFLO(TM)- and placebo-treated patients were similar and low (2.6% and 1.5%, respectively). In addition, the incidence of treatment-related ...
... a three-point improvement in IPSS score, regardless of age or severity of symptoms. RAPAFLO(TM) is associated with a low incidence of orthostatic hypotension and the associated symptoms of syncope, fainting and dizziness. "The launch of RAPAFLO(TM) is an important milestone and, coupled with the ...
... of care includes diuretics and vasodilators. Available agents from both of these classes of agents have been associated with renal impairment, hypotension and adverse outcomes. About Relaxin Relaxin is a naturally occurring peptide hormone that acts as a systemic and renal vasodilator ...
... prior to starting olanzapine. Patients receiving olanzapine should receive regular monitoring of weight. Olanzapine may induce orthostatic hypotension associated with dizziness, tachycardia, bradycardia, and in some patients, syncope, especially during the initial dose-titration period. Particular ...
... immediately available. The following serious adverse reactions have been reported with the use of LUSEDRA. -- Hypotension -- hypotension was reported in 18/455 (4%) patients treated with LUSEDRA using the standard or modified dosing regimen. -- Patients with ...
... not limited to, flushing, shortness of breath, facial swelling, headache, chills, back pain, tightness in the chest or throat, and/or hypotension have occurred in up to 10% of patients treated with DOXIL. In most patients, these reactions have resolved within several hours to a ...
... no pre-existing joint damage. The most serious adverse reactions are systemic hypersensitivity reactions including bronchospastic reactions and/or hypotension and anaphylaxis and the development of high-titer inhibitors necessitating alternative treatments to AHF. The most common adverse reactions observed ...
... an activated renin-angiotensin system, such as volume- and/or salt-depleted patients (e.g., those receiving high doses of diuretics), symptomatic hypotension may occur after initiation of MICARDIS therapy. This condition should be corrected prior to administration of MICARDIS tablets, and treatment should ...
... hallucination (7 percent vs. 3 percent), somnolence (7 percent vs. 4 percent), abdominal pain/discomfort (6 percent vs. 3 percent) and orthostatic hypotension (5 percent vs. 1 percent). A Progressively Disabling Disease Parkinson's disease is a chronic, progressive, and often disabling neurological ...
... the patients' longevity and quality of life without undue toxicities. The predominant side effects were chills, fever, headaches, and transient hypotension that were controlled with medications and fluid support." "It appears that infusions of targeted T cells have boosted the immune system to create a ...
... for patients with multiple myeloma after first relapse. Risks associated with VELCADE therapy include new or worsening peripheral neuropathy, hypotension observed throughout therapy, cardiac and pulmonary disorders, gastrointestinal adverse events, thrombocytopenia, neutropenia and tumor lysis ....
... for patients with multiple myeloma after first relapse. Risks associated with VELCADE therapy include new or worsening peripheral neuropathy, hypotension observed throughout therapy, cardiac and pulmonary disorders, gastrointestinal adverse events, thrombocytopenia, neutropenia and tumor lysis ....
... for patients with multiple myeloma after first relapse. Risks associated with VELCADE therapy include new or worsening peripheral neuropathy, hypotension observed throughout therapy, cardiac and pulmonary disorders, gastrointestinal adverse events, thrombocytopenia, neutropenia and tumor lysis ....
... an activated renin-angiotensin system, such as volume- and/or salt-depleted patients (e.g., those receiving high doses of diuretics), symptomatic hypotension may occur after initiation of MICARDIS therapy. This condition should be corrected prior to administration of MICARDIS tablets, and treatment should ...
... 0 2 5 2 Attention disturbance 0 5 0 2 hypotension 3 0 2 5 About Acute Migraine Headaches According to the National Headache Foundation, ...
... undergo fasting blood glucose testing. There have been few reports of hyperglycemia with ABILIFY ABILIFY may be associated with orthostatic hypotension and should be used with caution in patients with known cardiovascular disease, cerebrovascular disease, or conditions which would predispose them ...
... AEs included: dizziness (3.4 percent), hypotension (2.2 percent), and/or headache (1.1 percent). ... patients, 2.2%), headache (4 patients, 2.2%), and hypotension (4 patients, 2.2%). Among individual treatment ... Mortality in the prescribing information. hypotension in Volume- or Salt-Depleted Patients In ...
... Fetal/Neonatal Morbidity and Mortality. hypotension in Volume- or Salt-Depleted Patients In ... and/or salt-depleted patients, symptomatic hypotension due particularly to the olmesartan component may ... to amlodipine in AZOR is gradual in onset, acute hypotension has rarely been reported after oral ...
... include new or worsening peripheral neuropathy, hypotension throughout therapy, cardiac and pulmonary ... pain (each 15%), bone pain (14%), back pain and hypotension (each 13%), herpes zoster, nasopharyngitis, upper ... (13% vs 7%), abdominal pain upper (12% vs 9%), hypotension (12% vs 3%), dyspepsia (11% vs 7%), ...
... include new or worsening peripheral neuropathy, hypotension throughout therapy, cardiac and pulmonary ... pain (each 15%), bone pain (14%), back pain and hypotension (each 13%), herpes zoster, nasopharyngitis, upper ... (13% vs 7%), abdominal pain upper (12% vs 9%), hypotension (12% vs 3%), dyspepsia (11% vs 7%), ...
... include new or worsening peripheral neuropathy, hypotension throughout therapy, cardiac and pulmonary ... pain (each 15%), bone pain (14%), back pain and hypotension (each 13%), herpes zoster, nasopharyngitis, upper ... (13% vs 7%), abdominal pain upper (12% vs 9%), hypotension (12% vs 3%), dyspepsia (11% vs 7%), ...
... (13% vs 7%), abdominal pain upper (12% vs 9%), hypotension (12% vs 3%), dyspepsia (11% vs ... include new or worsening peripheral neuropathy, hypotension throughout therapy, cardiac and pulmonary ... pain (each 15%), bone pain (14%), back pain and hypotension (each 13%), herpes zoster, nasopharyngitis, upper ...
... as the incidence (%) in these 98 patients: hypotension (50%), back pain (30%), dyspnea (28%), ... type of treatment will depend on whether edema or hypotension is the primary clinical problem. Pre-existing low ... (61%), infection (48%), pain (48%), edema (47%), hypotension (36%), anorexia (36%), and rash (34%). ...
Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations
... Morbidity and Mortality. hypotension in Volume- or Salt-Depleted Patients In ... salt-depleted patients, symptomatic hypotension due particularly to the olmesartan component may ... to amlodipine in AZOR is gradual in onset, acute hypotension has rarely been reported after ...... resulted in accidents. Hallucinations and postural (orthostatic) hypotension may occur. In clinical trials for early PD using immediate release ... of pramipexole that were more frequent than with placebo are postural hypotension (53% vs. 48%), dyskinesia (47% vs. 31%), extrapyramidal syndrome (28% vs. ...
... Morbidity and Mortality in the prescribing information. hypotension in Volume- or Salt-Depleted Patients In patients with an activated ... (eg, those being treated with high doses of diuretics), symptomatic hypotension may occur after initiation of treatment with BENICAR. Treatment should ...
... Morbidity and Mortality in the prescribing information. hypotension in Volume- or Salt-Depleted Patients In patients with an activated ... (e.g., those being treated with high doses of diuretics), symptomatic hypotension may occur after initiation of treatment with BENICAR. Treatment should ...
... (29.9%), sneezing (16.3%), skin sensation (10.9%), nausea (9%), and hypotension (6.3%). These events were generally transient. Four serious AEs possibly or probably related to KYNAPID occurred in three patients and included hypotension (2 events), complete atrioventricular block and cardiogenic shock. About ...
Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting
... headache, chills, back pain, tightness in the chest or throat, and/or hypotension have occurred in up to 10% of patients treated with DOXIL. In most ... with VELCADE therapy include new or worsening peripheral neuropathy, hypotension observed throughout therapy, cardiac and pulmonary disorders, ...... proprietary products for the therapeutic management of acute and chronic hypotension and hypotension-related disorders. The lead development compound is a ... for Migraine, and MTR105 (i.v. formulation) for the treatment of hypotension associated with cardiac (CABG) surgery. Meditor's patent portfolio ...
FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications
... antipsychotic increase. The syndrome may remit, partially or completely, if antipsychotic treatment is withdrawn. Zyprexa may induce orthostatic hypotension associated with dizziness, tachycardia, bradycardia, and in some patients, syncope, especially during the initial dose-titration period. Particular ...... of care includes diuretics and vasodilators. Available agents from both of these classes of agents have been associated with renal impairment, hypotension and adverse outcomes. About Relaxin Relaxin is a naturally occurring peptide hormone that acts as a systemic and renal vasodilator. ...
... higher levels of prolactin elevation than other antipsychotic agents. Orthostatic Hypotension: RISPERDAL(R) CONSTA(R) may induce orthostatic hypotension associated with dizziness, tachycardia, and in some patients, syncope, especially during the initial dose-titration period. Monitoring should be ...
... treatment effect, led to treatment discontinuation in only 2.8 percent of patients, and does not pose a safety concern. Incidences of orthostatic hypotension among RAPAFLO(TM)- and placebo-treated patients were similar and low (2.6% and 1.5%, respectively). In addition, the incidence of treatment-related ...
... a three-point improvement in IPSS score, regardless of age or severity of symptoms. RAPAFLO(TM) is associated with a low incidence of orthostatic hypotension and the associated symptoms of syncope, fainting and dizziness. "The launch of RAPAFLO(TM) is an important milestone and, coupled with the ...
... of care includes diuretics and vasodilators. Available agents from both of these classes of agents have been associated with renal impairment, hypotension and adverse outcomes. About Relaxin Relaxin is a naturally occurring peptide hormone that acts as a systemic and renal vasodilator ...
... prior to starting olanzapine. Patients receiving olanzapine should receive regular monitoring of weight. Olanzapine may induce orthostatic hypotension associated with dizziness, tachycardia, bradycardia, and in some patients, syncope, especially during the initial dose-titration period. Particular ...
... immediately available. The following serious adverse reactions have been reported with the use of LUSEDRA. -- Hypotension -- hypotension was reported in 18/455 (4%) patients treated with LUSEDRA using the standard or modified dosing regimen. -- Patients with ...
... not limited to, flushing, shortness of breath, facial swelling, headache, chills, back pain, tightness in the chest or throat, and/or hypotension have occurred in up to 10% of patients treated with DOXIL. In most patients, these reactions have resolved within several hours to a ...
Whatcom County, Washington Participating in NIH Study of Cardiac Arrest Resuscitation Techniques
... are ongoing in the United States to evaluate the long-term benefit of the ResQPOD for indications related to patients suffering from cardiac arrest, hypotension during dialysis and severe blood loss. The references in this communication are not intended to imply specific outcome-based claims not yet cleared ...... no pre-existing joint damage. The most serious adverse reactions are systemic hypersensitivity reactions including bronchospastic reactions and/or hypotension and anaphylaxis and the development of high-titer inhibitors necessitating alternative treatments to AHF. The most common adverse reactions observed ...
... an activated renin-angiotensin system, such as volume- and/or salt-depleted patients (e.g., those receiving high doses of diuretics), symptomatic hypotension may occur after initiation of MICARDIS therapy. This condition should be corrected prior to administration of MICARDIS tablets, and treatment should ...
Nile Therapeutics Announces Dosing in Second Phase Ib Study of CD-NP in Heart Failure Patients
... for ADHF, including B-type natriuretic peptide, have been associated with favorable pharmacologic effects, but have also been associated with hypotension and decreased renal function which limit their utility in clinical practice. CD-NP was designed to preserve the favorable effects of current ...Nile Therapeutics Announces Dosing in Phase IIa Study of CD-NP in Heart Failure Patients
... for ADHF, including B-type natriuretic peptide, have been associated with favorable pharmacologic effects, but have also been associated with hypotension and decreased renal function which limit their utility in clinical practice. CD-NP was designed to preserve the favorable effects of current ...... hallucination (7 percent vs. 3 percent), somnolence (7 percent vs. 4 percent), abdominal pain/discomfort (6 percent vs. 3 percent) and orthostatic hypotension (5 percent vs. 1 percent). A Progressively Disabling Disease Parkinson's disease is a chronic, progressive, and often disabling neurological ...
... the patients' longevity and quality of life without undue toxicities. The predominant side effects were chills, fever, headaches, and transient hypotension that were controlled with medications and fluid support." "It appears that infusions of targeted T cells have boosted the immune system to create a ...
... for patients with multiple myeloma after first relapse. Risks associated with VELCADE therapy include new or worsening peripheral neuropathy, hypotension observed throughout therapy, cardiac and pulmonary disorders, gastrointestinal adverse events, thrombocytopenia, neutropenia and tumor lysis ....
... for patients with multiple myeloma after first relapse. Risks associated with VELCADE therapy include new or worsening peripheral neuropathy, hypotension observed throughout therapy, cardiac and pulmonary disorders, gastrointestinal adverse events, thrombocytopenia, neutropenia and tumor lysis ....
Two DOXIL(R) Studies to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
... but not limited to, flushing, shortness of breath, facial swelling, headache, chills, back pain, tightness in the chest or throat, and/or hypotension have occurred in up to 10% of patients treated with DOXIL. In most patients, these reactions have resolved within several hours to a day ...... for patients with multiple myeloma after first relapse. Risks associated with VELCADE therapy include new or worsening peripheral neuropathy, hypotension observed throughout therapy, cardiac and pulmonary disorders, gastrointestinal adverse events, thrombocytopenia, neutropenia and tumor lysis ....
PRoFESS(R) Results Announced at XVII European Stroke Conference
... an activated renin-angiotensin system, such as volume- and/or salt-depleted patients (e.g., those receiving high doses of diuretics), symptomatic hypotension may occur after initiation of MICARDIS therapy. This condition should be corrected prior to administration of MICARDIS tablets, and treatment should ...Clinical Update - Debio 0614 (Istaroxime) in Acute Heart Failure
... consumption," said Kamel Besseghir, CEO of Debiopharm S.A. "Compared to available inotropes, known to be associated with increase of heart rate, hypotension and increase in atrial or ventricular arrhythmias, Debio 0614 demonstrated a rapid improvement of pulmonary capillary wedge pressure, associated with ...... an activated renin-angiotensin system, such as volume- and/or salt-depleted patients (e.g., those receiving high doses of diuretics), symptomatic hypotension may occur after initiation of MICARDIS therapy. This condition should be corrected prior to administration of MICARDIS tablets, and treatment should ...
... 0 2 5 2 Attention disturbance 0 5 0 2 hypotension 3 0 2 5 About Acute Migraine Headaches According to the National Headache Foundation, ...
... undergo fasting blood glucose testing. There have been few reports of hyperglycemia with ABILIFY ABILIFY may be associated with orthostatic hypotension and should be used with caution in patients with known cardiovascular disease, cerebrovascular disease, or conditions which would predispose them ...
Other ContentswarmwarmwarmwarmwarmwarmwarmendosymbioticendosymbioticentomologyentomologyenhancerenhancerenhancerenhancerenhancerenhancerepidermisepidermisepidermisepidermisepidermisalcoholalcoholalcoholalcoholalcoholalcoholalcoholalcoholalcoholethylethylethylepigeneticsOther Tags
(Date:11/24/2009)...ter of debate. A high-profile study a few years ag...ir carbon from trees and leaves, evidence for a ve...ecosystems. , But new research from the Universi...ue. Algae provide a much richer diet for fish and ...d this week in the Proceedings of the National Ac...
(Date:11/23/2009)...ciated strain of the deadly superbug MRSAan infect...bioticsposes a far greater health threat than prev... according to a study in the December issue of Em...s easily picked up in fitness centers, schools, an...l burden of MRSA within hospitals, the report foun...
(Date:11/23/2009)...icipants gathered this week for the seventh annual...ence. This year,s topic, "Synthetic Biology," brou...searchers to explore the engineering, scientific, ...f synthetic biology. , Bonnie L. Bassler, profes...nd this year,s conference chair, challenged the at...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3New study finds MRSA on the rise in hospital outpatients 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Komen San Diego Ramps Up for Important Race for the Cure 28R 29 November 1 59157 1Komen San Diego Ramps Up for Important Race for the Cure 28R 29 November 1 59157 2Komen San Diego Ramps Up for Important Race for the Cure 28R 29 November 1 59157 3Komen San Diego Ramps Up for Important Race for the Cure 28R 29 November 1 59157 4Greenway Medical Technologies Continues to Lead the Evolution of Healthcare Automation at National Health IT Week in Washington D C 5345 1Greenway Medical Technologies Continues to Lead the Evolution of Healthcare Automation at National Health IT Week in Washington D C 5345 2Greenway Medical Technologies Continues to Lead the Evolution of Healthcare Automation at National Health IT Week in Washington D C 5345 3Greenway Medical Technologies Continues to Lead the Evolution of Healthcare Automation at National Health IT Week in Washington D C 5345 4Satellite Healthcare Tees Up With the National Kidney Foundation in Santa Cruz CA 5343 1Satellite Healthcare Tees Up With the National Kidney Foundation in Santa Cruz CA 5343 2(Date:11/26/2009)... Dr. David Kim of the Live Life Agai... in Dallas , is one of a growing number of physici...tworking sites to connect with individuals who are...ight morbid obesity. Dr. Kim is utilizing Facebook...about his practice with the community. , ...
(Date:11/25/2009)...SASCITY,Mo.,Nov.25/PRNewswire/--TheBartleHallConve...medicalcliniconDec.9-10,whenKansasCityhoststhelate... ,, "Thisfreecliniceventhasthepotentialtobetheb...ofjustoneandbeheldonweekdaysinsteadofoveraweekend,...lthClinicandpresidentoftheNationalAssociationofFre...
(Date:11/25/2009)...VERSPRING,Md.,Nov.25/PRNewswire-USNewswire/--Anart...orDrugEvaluationandResearch,titled"ADifficultBalan...heNov.26,2009issueofTheNewEnglandJournalofMedicine.../20090824/FDALOGO ) ,, Inthearticle,Woodcockdis...nmedicationforthosewhoneeditandmanagingtheriskspos...
(Date:11/25/2009)...rs have found evidence of a statistically signific... patients whose estrogen receptor (ER)-positive tu...a; at serine-118 (ER-alpha S118-P), according to a...in the Journal of the National Cancer Institute ....sistant to tamoxifen. Preclinical studies have sho...
(Date:11/25/2009)... Evaluation and treatment clinics to... Woodstock (Vocus) November 25, 2009 -- Centegra H...cines and H1N1 vaccine shots at four Centegra Prim...hipment of vaccine has arrived. The clinics are at... McHenry and will be open as follows: , ...
Breaking Medicine News(10 mins):Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4[1] Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients[1] Kansas City Prepares for Largest Free Health Clinic[1] FDA's Woodcock Discusses Pain Management and Drug Safety in Nov. 26, 2009 Issue of The New England Journal of Medicine[2] News brief: Estrogen receptor-alpha, breast cancer patients and tamoxifen response[0] Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1
miniSpOImmersolBTLCourierTransfusionCourierHydroChopperStingerPratsSIMULUSFPDIdentifiOR96xiIII90xiIII220xiIII
Other Tagsreliever 2charts 2timing 2timing 3timing 4timing 5fate 2fate 3fate 4determines 2determines 3determines 4determines 5determines 6class 2class 3class 4class 5class 6class 7class 8class 9class 10discovered 2discovered 3discovered 4discovered 5discovered 6discovered 7discovered 8discovered 9discovered 10
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |